BIRC5 and lymphoma: For example, clinical studies revealed that 60% of biopsy samples from neuroblastoma (stage3–4) patients [53], 53% of colon cancer [54], 50% of high-grade lymphomas [55] and 35% of gastric cancer [56] are survivin positive.